Senior insider sale
EVP, Chief Scientific Officer at IONIS PHARMACEUTICALS INC — senior position signals high conviction
$5.72M
67.39K shares
What this filing means
BENNETT C FRANK plans to sell 67.39K shares of IONIS PHARMACEUTICALS INC valued at approximately $5.72M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/7/2026ACC: 0001972481-26-000225
Officer· EVP, Chief Scientific Officer
Since Mar 2026
67.39K
Shares to sell
$5.72M
Approx. market value
67.39K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Stock Option Exercise
Cash
1/4/2021
46.85KOwned Shares
Equity Compensation
1/15/2020
20.54KTotal acquired67.39K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/4/2021 | Stock Option Exercise Cash | 46.85K | — |
1/15/2020 | Owned Shares Equity Compensation | 20.54K | — |
| Total | 67.39K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
67.39K
Market value
$5.72M
7/7/2026
Total
Units
67.39K
Value
$5.72M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/7/2026 | 67.39K | $5.72M | Nasdaq | Planned |
| Total | 67.39K | $5.72M | ||